- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02816567
Laparoscopic Surgery and Abdominal Compliance (COELIOCUR)
Laparoscopic Surgery and Abdominal Compliance Factors Including Neuromuscular Blocking Agents
Study Overview
Status
Detailed Description
Background and rationale. Abdominal laparoscopic surgery is widely used. The meet good conditions, the surgeons need a large enough workspace. Carbonic gaz is insufflated in the intraperitoneal space but limited by the induced pressure which usually must not be above 15mm mercury (Hg) because of subsequent organ failures. The relationship between pressure and gaz volume insufflated defines the abdominal compliance (ΔV/ΔP).
The use of neuromuscular blocking agents (NMBA) is often used during abdominal laparoscopic surgery in order to reduce abdominal tonus, create a sufficient laparoscopic workspace hence improving abdominal compliance. However, considering good working conditions could be achieved by the use of NMBA, other factors could be considered like body weight, length, BMI, surgical abdominal history, parity.
Main objective : To compare the working surgical conditions and the pneumoperitoinea volume obtained during abdominal laparoscopic surgery with and without initial NMBA use.
Hypothesis: The use of NMBA improve the incidence of good surgical working conditions.
Study Design : Randomized blinded clinical trial. Two patients groups are compared, one receiving NMBA and one receiving a placebo. Randomisation will be realised by 1/1 ratio in blocks of 4.
The primary outcome is a composite criteria : the obtention of laparoscopic workspace greater than 3 liters associated with an abdominal pressure lesser than 15mmHg and a good surgical rating scale.
A statistical analysis reveal that 90 patients in each group need to be included from estimated 90% satisfying surgical conditions in NMBA group and 70% in placebo group.
In the placebo group, when surgical conditions are not correct (insufflated volume lesser than 3 liters or surgeon dissatisfaction), NMBA are used. This define the secondary use of NMBA.
Methods :
Anesthesia will be induced in all patients by target controlled infusions of propofol and sufentanil respectively with initial targets of 6 microgram/ml and 0,4 ng/ml.
The initial NMBA bolus in the NMBA group is 0,15 mg/kg of cisatracurium. A similar volume of isotonic saline serum is used in the placebo group.
The abdomen is inflated to 5, 10 and 15 mmHg and volumes at each pressure level are measured in order to evaluate the abdominal compliance.
After those measures, the anesthesiologist is unblinded of NMBA use. If the workspace volume is lesser than 3 liters, or, in case of surgeon dissatisfaction (using the surgical rating scale), NMBA can be used, defining secondary NMBA used.
Anesthesia is maintained by continous infusions of propofol and sufentanil aiming BIS target of 40 to 60.
When used, curarisation is maintained by a continuous infusion of cisatracurium (0,06 to 0,12 mg/kg/h) targetting 0 or 1 TOF response.
Safety issues : During anesthesia induction, if ventilation or tracheal intubation difficulties were to happen, the anesthesiologist is unblinded and any anesthesia protocol can be used.
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Beny Charbit
- Phone Number: 33 326787029
- Email: bcharbit@chu-reims.fr
Study Locations
-
-
Reims
-
France, Reims, France, 51092
- Recruiting
- CHU Reims
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- elective abdominal laparoscopy (cholecystectomy, colectomy, gastric bypass, sleeve gastrectomy, hepatic resection, splenectomy, hernial surgery, explorative laparoscopy)
- >18 yo
- patients who accept the protocol and sign it
- patients affiliated at the social security
Exclusion Criteria:
- formal indication of NMBA use (predictive difficult tracheal intubation, predictive difficult facial ventilation)
- patients who needs a crush induction
- NMBA allergia
- patients who present a contraindication to the propofol or sufentanil
- pregnancy
- breastfeeding womens
- patients protected by the law
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: placebo group
|
|
Experimental: NMBA group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Volume of pneumoperiteum laparoscopic workspace
Time Frame: Day 0 (after anesthesia induction)
|
laparoscopic workspace assessed by volume of pneumoperiteum > 3 Liters
|
Day 0 (after anesthesia induction)
|
score SRS (Surgical Rating Scale)
Time Frame: Day 0 (after anesthesia induction)
|
Day 0 (after anesthesia induction)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Hypnotics and Sedatives
- Adjuvants, Anesthesia
- Neuromuscular Agents
- Neuromuscular Blocking Agents
- Propofol
- Sufentanil
- Cisatracurium
Other Study ID Numbers
- PA16045
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients Ongoing Elective Abdominal Laparoscopy
-
Duke UniversityCompleted
-
Betsi Cadwaladr University Health BoardCompletedElective Surgical Patients
-
Minia UniversityMinia University HospitalRecruitingPatients Undergoing Elective CraniotomyEgypt
-
National Defense Medical Center, TaiwanCompletedElective Cardiac Surgical PatientsTaiwan
-
National Cancer Institute, NaplesActive, not recruitingPatients Undergoing Elective ColonoscopyItaly
-
Isfahan University of Medical SciencesUnknownElective Craniotomy-candidated PatientsIran, Islamic Republic of
-
Tokyo Women's Medical UniversityBaxter Healthcare CorporationUnknownPatients Undergoing Elective CraniotomyJapan
-
Mansoura UniversityCompletedElective Major Abdominal SurgeryEgypt
-
Mansoura UniversityCompleted
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAnesthesia for Elective Surgery PatientsChina
Clinical Trials on sufentanil
-
University Hospital Hradec KraloveCompleted
-
AcelRx Pharmaceuticals, Inc.Completed
-
AcelRx Pharmaceuticals, Inc.Completed
-
More FoundationRecruiting
-
AcelRx Pharmaceuticals, Inc.Completed
-
University Hospital Schleswig-HolsteinCompletedBalanced AnesthesiaGermany
-
University Hospital, ToulouseCompletedAnaesthetic InductionFrance
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
Jin NiUnknownTonsillitis | Adenoid Hypertrophy | Sleep Breathing DisordersChina